Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Blinking and Yawning in Epilepsy: The Role of Dopamine (BYE BYE DOPA)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT01432821
First received: June 14, 2011
Last updated: November 4, 2016
Last verified: November 2016